DE60023941D1 - Methoden für organ-dezellularisierung - Google Patents

Methoden für organ-dezellularisierung

Info

Publication number
DE60023941D1
DE60023941D1 DE60023941T DE60023941T DE60023941D1 DE 60023941 D1 DE60023941 D1 DE 60023941D1 DE 60023941 T DE60023941 T DE 60023941T DE 60023941 T DE60023941 T DE 60023941T DE 60023941 D1 DE60023941 D1 DE 60023941D1
Authority
DE
Germany
Prior art keywords
organ
methods
decellularized
isolated
remove
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023941T
Other languages
English (en)
Inventor
Anthony Atala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23884532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60023941(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Application granted granted Critical
Publication of DE60023941D1 publication Critical patent/DE60023941D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
DE60023941T 1999-12-29 2000-12-14 Methoden für organ-dezellularisierung Expired - Lifetime DE60023941D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/474,678 US6376244B1 (en) 1999-12-29 1999-12-29 Methods and compositions for organ decellularization
PCT/US2000/033782 WO2001049210A1 (en) 1999-12-29 2000-12-14 Methods and compositions for organ decellularization

Publications (1)

Publication Number Publication Date
DE60023941D1 true DE60023941D1 (de) 2005-12-15

Family

ID=23884532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023941T Expired - Lifetime DE60023941D1 (de) 1999-12-29 2000-12-14 Methoden für organ-dezellularisierung

Country Status (9)

Country Link
US (3) US6376244B1 (de)
EP (1) EP1244396B2 (de)
JP (1) JP4897176B2 (de)
AT (1) ATE308939T1 (de)
AU (1) AU763730B2 (de)
CA (1) CA2395637C (de)
DE (1) DE60023941D1 (de)
ES (1) ES2250220T5 (de)
WO (1) WO2001049210A1 (de)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2306841T3 (es) 1996-08-23 2008-11-16 Cook Biotech, Inc. Protesis para injertos con base de colageno.
US6576019B1 (en) * 1997-10-31 2003-06-10 Children's Medical Center Corporation Bladder reconstruction
US20030217415A1 (en) * 1998-06-30 2003-11-27 Katrina Crouch Plasticized bone grafts and methods of making and using same
US8563232B2 (en) * 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US7063726B2 (en) * 1998-06-30 2006-06-20 Lifenet Plasticized bone grafts and methods of making and using same
US6293970B1 (en) 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
US20100030340A1 (en) * 1998-06-30 2010-02-04 Wolfinbarger Jr Lloyd Plasticized Grafts and Methods of Making and Using Same
US6734018B2 (en) 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6743574B1 (en) 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6214054B1 (en) * 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
US20040043006A1 (en) * 2002-08-27 2004-03-04 Badylak Stephen F. Tissue regenerative composition
US20050249816A1 (en) * 1999-12-29 2005-11-10 Wake Forest University Health Services Tissue engineered liver constructs
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
EP1315796B1 (de) 2000-08-16 2006-07-12 Duke University Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe
US20020119437A1 (en) * 2000-09-20 2002-08-29 Grooms Jamie M. Method of preparing and processing transplant tissue
IL139708A0 (en) * 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
US20070286845A1 (en) * 2000-11-17 2007-12-13 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US8071740B2 (en) * 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US8039261B2 (en) * 2000-11-17 2011-10-18 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US20100282634A1 (en) * 2000-11-17 2010-11-11 Dror Harats Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
AU2003222427B8 (en) 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
DE10064948C1 (de) * 2000-12-20 2002-07-11 Auto Tissue Gmbh Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens
WO2002063962A1 (en) * 2001-02-14 2002-08-22 Hariri Robert J Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2003002165A1 (en) * 2001-06-28 2003-01-09 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
DE10138564B4 (de) * 2001-08-06 2007-07-12 Lamm, Peter Wilhelm, Dr. Verfahren zur Devitalisierung natürlicher Organe und/oder zur Bereitstellung extrazellulärer Matrices zum "Tissue-Engineering"
EP2277887A3 (de) 2001-10-19 2011-02-16 Vascular Biogenics Ltd. Polynukleotidkonstrukte, pharmazeutische Zusammensetzungen und Verfahren zur gezielten Abwärtsregulation der Angiogenese und Therapie gegen Krebs
EP1317934A1 (de) * 2001-11-08 2003-06-11 Artiss GmbH Verfahren zur Herstellung einer azellularisierten Gewebematrix und damit erhältliche Gewebematrix
JP2005509495A (ja) * 2001-11-16 2005-04-14 チルドレンズ メディカル センター コーポレーション 臓器の機能の増強
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20030215935A1 (en) * 2002-05-14 2003-11-20 Coon David James Apparatus and method for isolating living cells from an encapsulated organ tissue sample
CA2491528A1 (en) * 2002-06-28 2004-01-08 Cardio, Inc. Decellularized tissue
US7402319B2 (en) * 2002-09-27 2008-07-22 Board Of Regents, The University Of Texas System Cell-free tissue replacement for tissue engineering
US8940292B2 (en) 2003-01-28 2015-01-27 Wake Forest University Health Sciences Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7488348B2 (en) * 2003-05-16 2009-02-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
CA2530490A1 (en) * 2003-06-25 2005-01-13 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
US20050054099A1 (en) * 2003-09-04 2005-03-10 Cedars Sinai Medical Center Matrix derived from whole organ
US7763459B2 (en) * 2003-10-02 2010-07-27 Depuy Spine, Inc. Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
US7775965B2 (en) * 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7759120B2 (en) * 2005-03-02 2010-07-20 Kps Bay Medical, Inc. Seeding implantable medical devices with cells
US20060199265A1 (en) * 2005-03-02 2006-09-07 Wolf Michael F Seeding implantable medical devices with cells
EP1902127B1 (de) 2005-04-15 2012-08-29 Wake Forest University Health Sciences Bioreaktorsystem und verfahren zur verbesserung der funktionalität von in vitro kultiviertem muskel
US9788821B2 (en) * 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
DE102005023599A1 (de) 2005-05-18 2006-11-23 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Bioartifizielles Herzgewebetransplantat und Verfahren zu seiner Herstellung
US20070038298A1 (en) * 2005-06-30 2007-02-15 Sulner Joseph W Repair of tympanic membrane using placenta derived collagen biofabric
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
AU2013224686B2 (en) * 2005-08-26 2015-06-11 Miromatrix Medical Inc. Decellularization and recellularization of organs and tissues
KR101376013B1 (ko) * 2005-08-26 2014-03-19 리전츠 오브 더 유니버스티 오브 미네소타 기관 및 조직의 세포제거 및 재세포화
AU2015224503A1 (en) * 2005-08-26 2015-10-01 Regents Of The University Of Minnesota Decellularization and recellularization of organs and tissues
US20100093066A1 (en) 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US20070143143A1 (en) * 2005-12-16 2007-06-21 Siemens Medical Solutions Health Services Corporation Patient Discharge Data Processing System
WO2007124127A2 (en) * 2006-04-21 2007-11-01 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
CA2654716A1 (en) * 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
US8105634B2 (en) * 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
NZ576372A (en) 2006-10-06 2012-02-24 Anthrogenesis Corp Native (telopeptide) placental collagen compositions
EP2077718B2 (de) 2006-10-27 2022-03-09 Edwards Lifesciences Corporation Biologisches gewebe für chirurgische implantation
WO2008059244A2 (en) 2006-11-16 2008-05-22 University Of Leeds Preparation of tissue for meniscal implantation
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
JP5331960B2 (ja) 2007-03-09 2013-10-30 国立大学法人 東京医科歯科大学 脱細胞化軟組織の調製方法、移植片、及び培養部材
WO2008150814A2 (en) 2007-05-29 2008-12-11 Reid Christopher B Methods for production and uses of multipotent cell populations
US9580688B2 (en) * 2007-06-08 2017-02-28 Wake Forest University Health Sciences Kidney structures and methods of forming the same
WO2008153970A1 (en) 2007-06-08 2008-12-18 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
US9101691B2 (en) * 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
JP2009050297A (ja) * 2007-08-23 2009-03-12 Tokyo Medical & Dental Univ 脱細胞処理液、脱細胞化組織の調製方法、移植片、及び培養部材
JP5218955B2 (ja) * 2007-10-15 2013-06-26 独立行政法人物質・材料研究機構 再生用多孔質足場材およびその製造方法
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US11051733B2 (en) * 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
JP2011525140A (ja) * 2008-06-20 2011-09-15 クック・バイオテック・インコーポレイテッド 複合細胞外マトリックス材料およびそれらから形成される医療製品
MX2011001992A (es) 2008-08-22 2011-03-29 Anthrogenesis Corp Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
CN104274256A (zh) * 2008-11-04 2015-01-14 坦吉恩股份有限公司 细胞支架构建体
EP3388509A1 (de) 2008-11-12 2018-10-17 inRegen Isolierte nierenzellen und verwendungen davon
WO2010057013A1 (en) * 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
US9150318B1 (en) 2009-01-02 2015-10-06 Lifecell Corporation Method for sterilizing an acellular tissue matrix
WO2010099310A1 (en) 2009-02-26 2010-09-02 Wake Forest University Health Sciences Endothelial scaffolds
WO2010111263A1 (en) 2009-03-23 2010-09-30 Wake Forest University Health Sciences Tissue engineering scaffolds and methods of use
US20110045045A1 (en) * 2009-07-07 2011-02-24 Joaquin Cortiella Production of and uses for decellularized lung tissue
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8507263B2 (en) * 2009-08-07 2013-08-13 Maria Adelaide Asnaghi Rotating bioreactor
JP2011041716A (ja) * 2009-08-21 2011-03-03 Cell Remover:Kk 生体組織の処理方法
US20110236949A1 (en) * 2009-09-22 2011-09-29 Colorado State University Research Foundation Methods for Processing Biological Tissues
MX2012004037A (es) 2009-10-07 2012-10-15 Kerecis Ehf Material de andamiaje para el cuidado de heridas y/u otras aplicaciones para cicatrizacion de tejido.
JP2011135836A (ja) * 2009-12-28 2011-07-14 Cell Remover:Kk 細胞培養基材
EP2542668A2 (de) * 2010-03-01 2013-01-09 Colibri Heart Valve LLC Gewebe für prothetische implantate und pfropfe sowie damit zusammenhängende verfahren
NZ602706A (en) 2010-03-23 2014-02-28 Edwards Lifesciences Corp Methods of conditioning sheet bioprosthetic tissue
EP2555783A1 (de) 2010-04-08 2013-02-13 Anthrogenesis Corporation Behandlung von sarkoidose mithilfe von stammzellen aus der plazenta
US8883210B1 (en) * 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CA2806544C (en) 2010-06-28 2016-08-23 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
KR101900116B1 (ko) 2010-09-01 2018-09-18 리전츠 오브 더 유니버스티 오브 미네소타 개선된 이식가능성을 위한 조직 또는 장기의 재세포화 방법
TWI607757B (zh) 2010-11-10 2017-12-11 英瑞金公司 治療製劑
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
JP2014507179A (ja) 2010-12-14 2014-03-27 コリブリ ハート バルブ エルエルシー 統合された弁尖を伴う折り畳まれた膜の心臓弁膜尖を含む経皮的にデリバリー可能な心臓弁
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US20130143323A1 (en) * 2011-06-01 2013-06-06 Geoffrey S. FROST Apparatus and method for decellularizing, recellularizing or treating organs
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
WO2013089808A1 (en) * 2011-12-14 2013-06-20 Edmund Burke Decellularized small particle tissue
US20130288973A1 (en) * 2011-12-14 2013-10-31 Edmund Burke Decellularized small particle tissue
EP2809152B1 (de) 2012-02-01 2019-11-20 Nayacure Therapeutics Ltd Verfahren zur induktion von immuntoleranz bei organtransplantationen
CN104411816B (zh) 2012-03-16 2018-01-02 诺瓦赫普有限公司 经生物工程改造的同种异体血管
EP2841010B1 (de) 2012-04-24 2023-08-23 Harvard Apparatus Regenerative Technology, Inc. Träger für künstliche gewebegerüste
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
US20140377227A1 (en) * 2012-11-07 2014-12-25 James Bennie Gandy Tissue Transplantation Involving, and Tissues Modified by Decellularization And Recellularization Of Donor Tissues For Minimized Or Obviated Rejection Reactions
CA2890661A1 (en) * 2012-11-07 2014-07-10 James Bennie Gandy Tissue transplantation involving, and tissues modified by decellularization and recellularization of donor tissues for minimized or obviated rejection reactions
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
WO2014110300A1 (en) 2013-01-09 2014-07-17 Harvard Apparatus Regenerative Technology Synthetic scaffolds
KR20150126841A (ko) 2013-03-07 2015-11-13 알로소스 일관된 칼슘 함량 골 동종이식편 시스템 및 방법
CN105164250A (zh) 2013-03-15 2015-12-16 米罗马特里克斯医疗公司 灌注脱细胞化的肝脏在胰岛细胞再细胞化中的用途
WO2014181767A1 (ja) 2013-05-07 2014-11-13 国立大学法人 東京医科歯科大学 粒子状脱細胞化組織の製造方法
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
CN107670109A (zh) 2014-05-27 2018-02-09 诺瓦赫普有限公司 经生物工程改造的同种异体瓣膜
CN104208751A (zh) * 2014-08-19 2014-12-17 温州医科大学 一种新型肾脏去细胞生物支架的制备方法
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US20180028722A1 (en) 2015-02-27 2018-02-01 Adeka Corporation Decellularized tissue
BR112017018772B1 (pt) 2015-03-12 2021-09-21 Km Biologics Co., Ltd. Material antiadesão, método para a preparação e kit do referido material e biomembrana substituta, método para a preparação e kit da referida membrana
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
GB201513461D0 (en) * 2015-07-30 2015-09-16 Ucl Business Plc Methods and devices for the production of decellularised tissue scaffolds
NZ741377A (en) 2015-10-09 2022-02-25 Deka Products Lp Fluid pumping and bioreactor system
AU2017286715B2 (en) 2016-06-15 2022-03-03 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
US11278643B2 (en) 2016-09-06 2022-03-22 Mayo Foundation For Medical Education And Research Use of resected liver serum for whole liver-engineering
US11299705B2 (en) 2016-11-07 2022-04-12 Deka Products Limited Partnership System and method for creating tissue
WO2018127554A1 (en) 2017-01-06 2018-07-12 Novahep Ab Methods of preparing bioengineered or bioprinted organ or tissue, and uses thereof
EP3632481B1 (de) 2017-05-30 2023-08-23 Adeka Corporation Verfahren zur herstellung von dezellularisiertem material für transplantation und transplantatzusammensetzung mit biokompatiblem material mit einem solchen material
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
CN107596446B (zh) * 2017-09-16 2020-07-28 温州医科大学 一种维持组织超微结构和营养微环境的脱细胞试剂盒
CA3107918A1 (en) 2018-08-03 2020-02-06 VeriGraft AB Methods of preparing personalized blood vessels
EP3852683A1 (de) 2018-11-01 2021-07-28 Edwards Lifesciences Corporation Pulmonales regeneratives transkatheterventil
JP2022516562A (ja) 2019-01-07 2022-02-28 ミロマトリックス メディカル インコーポレイテッド 細胞外マトリクスの脱水方法およびそれにより形成される粒子
CN116437973A (zh) 2020-08-06 2023-07-14 康干细胞生物科技有限公司 使用适配体制备高功能人造器官的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458678A (en) 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
US4520821A (en) 1982-04-30 1985-06-04 The Regents Of The University Of California Growing of long-term biological tissue correction structures in vivo
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5160490A (en) 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5567612A (en) 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5759830A (en) 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5336616A (en) * 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
WO1993007913A1 (en) 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
KR100365573B1 (ko) 1994-03-14 2004-08-25 크라이어라이프, 인크. 이식용처리조직및이의제조방법
US5916265A (en) 1994-03-30 1999-06-29 Hu; Jie Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
CA2214407C (en) 1995-04-07 2008-06-17 Purdue Research Foundation Tissue graft and method for urinary bladder reconstruction
ZA963151B (en) * 1995-04-19 1997-04-24 St Jude Medical Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
DE59803925D1 (de) * 1997-06-27 2002-05-29 Augustinus Bader Bioartifizielles transplantat und verfahren zu seiner herstellung
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization

Also Published As

Publication number Publication date
ATE308939T1 (de) 2005-11-15
AU2095001A (en) 2001-07-16
EP1244396B1 (de) 2005-11-09
US20020102727A1 (en) 2002-08-01
JP2003518981A (ja) 2003-06-17
EP1244396B2 (de) 2009-02-11
CA2395637A1 (en) 2001-07-12
AU763730B2 (en) 2003-07-31
WO2001049210A1 (en) 2001-07-12
US6376244B1 (en) 2002-04-23
EP1244396A1 (de) 2002-10-02
US20030215945A1 (en) 2003-11-20
JP4897176B2 (ja) 2012-03-14
ES2250220T5 (es) 2009-05-01
CA2395637C (en) 2005-05-24
US6753181B2 (en) 2004-06-22
ES2250220T3 (es) 2006-04-16

Similar Documents

Publication Publication Date Title
DE60023941D1 (de) Methoden für organ-dezellularisierung
DK0987998T3 (da) Decellulering af væv
ATE419755T1 (de) Hochleistungsproteinextraktion
ATE357251T1 (de) Impfstoff enthaltend ein iscom, bestehend aus sterol und saponin und frei von zusätzlichen detergenzien
ATE256483T1 (de) Vorrichtungen zur risikoverminderung von stasis im herzvorhof
ATE507576T1 (de) Ionenextraktionseinrichtungen und verfahren zur selektiven extraktion von ionen
DE69813898D1 (de) Substituierte porphyrinen
DK0984665T3 (da) Transducer til delvis eller fuldstændig implanterbart höreapparat
BR0210718A (pt) Método para o tratamento de material celulósico, e, tecido
ATE359279T1 (de) Moschus-geruchsstoffe
ATE311206T1 (de) Substituierte porphyrine
ATE260675T1 (de) Methoden zur behandlung der salzabhängigen hypertonie
ATE499070T1 (de) Saugstent
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
DE69936285D1 (de) INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA
ATE426628T1 (de) Polyurethanderivatzusammensetzungen und verfahren zu ihrer herstellung
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
DK0814834T3 (da) Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE502007005857D1 (de) Isoliertes naturidentisches kollagen
DK1147420T3 (da) Urintrypsininhibitor til diagnosticering af AIDS
BRPI0416391A (pt) composições de limpeza
ATE259379T1 (de) Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung

Legal Events

Date Code Title Description
8332 No legal effect for de